NEW YORK (GenomeWeb News) – Bayer Healthcare has expanded a ten-year license agreement for Genedata’s software to include all of Bayer Schering Pharma’s drug research sites, Genedata said today.
The global agreement builds on a relationship dating back to 1999 and expands a renewed agreement from 2006 that gave Bayer Schering access to Genedata’s Phylosopher and Expressionist software at sites in the US and in Germany.
Genedata said it also will support integration services and will provide interfaces to existing research logistics infrastructure such as lab technologies and related IT systems.
Phylosopher is used to manage biological target information and Expressionist is used in quality control of gene expression data, for statistical analysis, and for processing data from high-throughput studies.
Financial terms of the agreement were not released.